Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

BOSTON, Oct. 22, 2018 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, announced... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Proteostasis Therapeutics, Inc.

Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock

PALO ALTO, Calif., Oct. 22, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced that it has commenced an underwritten public offering of its common stock. Eiger... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Eiger BioPharmaceuticals, Inc.

Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018

LA JOLLA, Calif., Oct. 22, 2018 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it will... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Regulus Therapeutics Inc.

Global Viral Vector Manufacturing Research Report 2018

DUBLIN, Oct. 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018

Vanda Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 7, 2018

WASHINGTON, Oct. 22, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter of 2018 on Wednesday, November 7, 2018, after the market closes.

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Vanda Pharmaceuticals

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2018 Financial Results

SOUTH PLAINFIELD, N.J., Oct. 22, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its third quarter 2018 financial results and provide an update on the company's business and outlook on Monday, November 5,... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  PTC Therapeutics, Inc.

Global Stem Cell and Regenerative Medicine Market Demand Analysis & Opportunity Report 2018: Market is Expected to Garner USD 14.74 Billion by the End of 2024

DUBLIN, Oct. 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018

Study Shows Volunteering Benefits Those with Lupus

CHICAGO, Oct. 22, 2018 PRNewswire/ -- Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery (HSS) shows that to be true for people with lupus volunteering in a peer support and education program.

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018

Neovasc Announces Successful Tiara(TM) "Live Case" at the 32nd Annual EACTS 2018 Meeting

NASDAQ, TSX: NVCN

Read more ››
By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  NEOVASC INC.

Premier Diagnostic Imaging Successfully Deploys eRAD RIS and PACS

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  ERAD THERAPEUTICS CANADA INC.

Ossur Hf : Transactions in relation to share buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Össur Nordic AB | Össur Germany | Össur Americas, Inc.

Sanofi: Disclosure of trading in own shares

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

Q-Centrix Celebrates Eight Years of Growth and the Quality Contributions of Hospitals and Healthcare Quality Professionals Everywhere During HQW 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

AB Science announces that the masitinib phase 3 study in Alzheimer's disease has completed patient recruitment

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  AB Science SA

Tabula Rasa HealthCare Participates in 2018 National PACE Association Conference

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Tabula Rasa HealthCare

POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Galapagos NV

Scientus Pharma Obtains Health Canada Approval for Cannabis Oils and Softgel Production

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Scientus Pharma Inc.

Marrone Bio Innovations Pest Management Products Win the International Biocontrol Manufacturers Association’s Bernard Blum Award for a Novel Biocontrol Solution

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Marrone Bio Innovations, Inc.

BIOPHYTIS : Interim Results 2018 and Perspective on Activity

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Biophytis S.A.

East River BioSolutions Awarded NIH SBIR Phase I Grant

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- East River BioSolutions announced it has been awarded a $224,566 SBIR Phase I grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health ("NIH"). The award will support further development of a fibrotic lung-specific cell... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  East River Biosolutions, Inc.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑